Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / BRSCW Application: Lokshin - Univ of Pitts (2008)

BRSCW Application: Lokshin - Univ of Pitts (2008)

288
TgII, SCC, HSP 70, IGFBP-1,2, GH, sICAM-1, MMP-9, MPO, tPAI-1, CA72-4, CA15-3, EGFR, Osteopontin (OPN), Endostatin (RNDO), Thrombospondin (THBS), Angiostatin (ANGIO), Apolipoproteins (Apo) A1, A2, B, E), Resistin, and PAI-1
Case/control
Proteomics
Breast and Gynecologic Cancers Research

One KLK,(KLK6) ranked 6th among all tested biomarkers(approx.50)

1.   Validation of ovarian cancer biomarkers (pre- and post-menopausal women) 2.   Validation of breast cancer biomarkers
Luminex

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


Announcement 10/07/2014

EDRN Patient Advocates will host an EDRN Advocacy Educational Webinar, Biomarkers for Prostate Cancer Detection and Monitoring, on Monday, January 12th, 2015, at 1 p.m. EDT / 10 a.m. PDT. Registration is not required for this. Please click for more information.
Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.